CHIMERA PEPTIDES: A NEW THERAPEUTIC FRONTIER

Chimera peptides represent a significantly evolving domain in drug research, presenting a novel strategy to target previously intractable diseases. These engineered structures merge various peptide segments, enabling for improved binding to diverse targets and potentially avoiding drug immunity.